Art

J-GLOBAL ID：200902212462495403   Reference number：04A0209524

Chemohormonal therapy as primary treatment for metastatic prostate cancer: A randomized study of estramustine phosphate plus luteinizing hormonereleasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist

転移性前立腺癌の一次治療としての化学ホルモン療法:フルタミド+黄体形成ホルモン放出ホルモン作動薬に対するエストラムスチンホスファート+黄体形成ホルモン放出ホルモン作動薬の無作為化研究

Author (6)： NOGUCHI M (Kurume Univ. School of Medicine, Kurume, JPN) ,  NODA S (Kurume Univ. School of Medicine, Kurume, JPN) ,  YOSHIDA M (Kumamoto Univ., Kumamoto, JPN) ,  UEDA S (Mie Univ., Mie, JPN) ,  SHIRAISHI T (Mie Univ., Mie, JPN) ,  ITOH K (Kurume Univ. School of Medicine, Kurume, JPN)
Material： International Journal of Urology  (Int J Urol)
Volume： 11  Issue： 2  Page： 103-109  Publication year： Feb. 2004 
JST Material Number： W1347A  ISSN： 0919-8172  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *prostatic tumor ,...
Semi thesaurus term： *LH-RH ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0209524&from=J-GLOBAL&jstjournalNo=W1347A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Urogenital tumors(=neoplasms)  (GM04000S)

Substance index (4)： Flutamide ,  Goserelin ,  Leuprorelin acetate ,  Estramustine phosphate

Reference (21)：

• HOWARD, GCW. The management of carcinoma of the prostate after failed primary therapy. Br. J. Urol. 1993, 72, 269-273
• LABRIE, F. New approach in the treatment of prostate cancer : Complete instead of partial withdrawal of androgens. Prostate. 1983, 4, 579-594
• Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer : an overview of the randomised trials. Lancet. 2000, 355, 1491-1499
• ISSACS, JT. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer toe androgen ablation therapy studied in the Dunning R.-3327-H adenocarcinoma. Cancer Res. 1981, 41, 5070-5075
• PERRY, CA. Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer. Drugs Aging. 1995, 7, 49-74

Terms in the title (8)： 転移性前立腺癌 ,  一次治療 ,  化学ホルモン療法 ,  フルタミド ,  黄体形成ホルモン放出ホルモン ,  作動薬 ,  エストラムスチンホスファート ,  研究